n.a. (CPHD)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)

Latest News

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cepheid And Encourages Shareholders To Contact The Firm For Additional Information

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cepheid And Encourages Shareholders To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Cepheid...

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cepheid And Encourages Shareholders To Contact The Firm For Additional Information

INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cepheid And Encourages Shareholders To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Cepheid...

Cepheid (CPHD) Stock Downgraded to 'Neutral' at Baird

Cepheid (CPHD) Stock Downgraded to 'Neutral' at Baird

Cepheid's (CPHD) stock rating was cut to 'neutral' at Baird on Monday morning.

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cepheid And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Cepheid And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Cepheid...

Cepheid (CPHD) Stock Price Target Raised at Barclays on Danaher Deal

Cepheid (CPHD) Stock Price Target Raised at Barclays on Danaher Deal

Barclays hiked Cepheid's (CPHD) stock price target to $52 on Wednesday after Danaher (DHR) agreed to buy the company for $4 billion yesterday.

Abbott's Alere Pushback Could Color Future Dealmaking Efforts

Abbott's Alere Pushback Could Color Future Dealmaking Efforts

Potential targets of the medical device and diagnostics giant might request stricter parameters when structuring a deal, company followers say.

Jim Cramer's 'Mad Money' Recap: These Stocks Will Rise, Whatever the Fed Does

Jim Cramer's 'Mad Money' Recap: These Stocks Will Rise, Whatever the Fed Does

Mergers and high-growth stocks are making the market better and better, Cramer says.

Stocks See Slight Gains as September Rate Hike Chances Shrink

Stocks See Slight Gains as September Rate Hike Chances Shrink

Weaker chances of a rate hike when the Federal Reserve meets in two weeks left Wall Street in a bright mood on its return from the long Labor Day weekend.

Cramer: Stocks That Defy the Fed's Gravitational Pull

Cramer: Stocks That Defy the Fed's Gravitational Pull

These names show the downward pull can be beaten with the right set of circumstances, and it happens more often than you might think.

Stocks Hold Slight Gains Amid Weaker U.S. Services Activity, Oil Rises

Stocks Hold Slight Gains Amid Weaker U.S. Services Activity, Oil Rises

Stocks hold slight gains through to mid-afternoon Tuesday after weaker U.S. services activity pushes back the chances of a September interest rate hike.

CEPHEID SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Danaher Corporation

CEPHEID SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Danaher Corporation

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Cepheid...

Cepheid (CPHD) Stock Surges, to be Acquired by Danaher for $4 Billion

Cepheid (CPHD) Stock Surges, to be Acquired by Danaher for $4 Billion

Danaher (DHR) said on Tuesday that it will purchase Cepheid (CPHD) for $4 billion in cash.

Stocks Turn Mixed as Services Activity Sees Slowest Growth Since 2010

Stocks Turn Mixed as Services Activity Sees Slowest Growth Since 2010

Stocks hold mixed by mid-morning Tuesday after U.S. services activity last month declines more than expected.

Stock Futures Edge Higher as Wall Street Mulls Fed's Next Move

Stock Futures Edge Higher as Wall Street Mulls Fed's Next Move

Stock futures edge higher in the return from the long Labor Day weekend as markets continue to mull over the Federal Reserve's next big move.

Danaher Bolsters Diagnostics Business With Cepheid Purchase

Danaher Bolsters Diagnostics Business With Cepheid Purchase

The recently slimmed-down buyer will pay $4 billion including debt for the molecular diagnostics specialist.

Insider Trading Alert - CPHD, WM And RTEC Traded By Insiders

Insider Trading Alert - CPHD, WM And RTEC Traded By Insiders

Stocks with insider trader activity include CPHD, WM and RTEC

'Mad Money' Lightning Round: I'm Still With Opko Health

'Mad Money' Lightning Round: I'm Still With Opko Health

Cramer wants you to stick with Abbvie and says Cepheid is working.

Jim Cramer's 'Mad Money' Recap: Four Winning Themes, Four to Avoid

Jim Cramer's 'Mad Money' Recap: Four Winning Themes, Four to Avoid

Cramer has seen enough in this earnings season to come to some conclusions on what's working and what isn't.

These 2 Undervalued Health Care Stocks Are Poised to Break Higher

These 2 Undervalued Health Care Stocks Are Poised to Break Higher

Shares of Cepheid and Hologic are oversold and are on their way up.

Bearish Bets: 5 Retail, Industrial and Education Stocks That Look Good Short

FOSL, CPHD, BWA, BPI and AP were all recently downgraded by TheStreet’s Quant Ratings.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AF, ANET, CCU, CROX, ENBL, GRBK, HCCI, LBTYA, PFIN, RIGP, TIME, UNAM, ZION Downgrades: ABEV, BPI, CPHD, LEE, PBIP, UG Initiations: HTGM, OPGN Read on to get TheStreet Quant Ratings' detailed report:

Today's Dead Cat Bounce Stock: Cepheid (CPHD)

Today's Dead Cat Bounce Stock: Cepheid (CPHD)

Trade-Ideas LLC identified Cepheid (CPHD) as a "dead cat bounce" (down big yesterday but up big today) candidate

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AIRM, AKS, AVX, AWH, BWA, CPHD, CVV, DD, EMXX, MAS, NANO, NTP, PEBO, PMD, PNR, POL, QLIK, SRDX, STAY, TILE, WCC, WWW, ZIXI Downgrades: ARI, CTG, STL Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Cepheid (CPHD) Stock Price Target Upped at Canaccord

Cepheid (CPHD) Stock Price Target Upped at Canaccord

Cepheid’s (CPHD) price target was increased at Canaccord, which also maintained its ‘hold’ rating on the stock.

Analysts' Actions -- Gap, Genuine Parts, Square, Intuitive Surgical and More

Analysts' Actions -- Gap, Genuine Parts, Square, Intuitive Surgical and More

Here are Monday's top research calls, including an upgrade for Gap, and downgrades for Genuine Parts, Intuitive Surgical and Square.

Short Interest Drops 12.6% For CPHD

Short Interest Drops 12.6% For CPHD

The most recent short interest data has been released by the NASDAQ for the 02/12/2016 settlement date, which shows a 710,766 share decrease in total short interest for Cepheid , to 4,936,354, a decrease of 12.59% since 01/29/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Trade-Ideas: Cepheid (CPHD) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: Cepheid (CPHD) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified Cepheid (CPHD) as a strong on high relative volume candidate